Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lingye Liu"'
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 42:371-381
Roflumilast is a selective, oral phosphodiesterase 4 inhibitor approved for the treatment of severe chronic obstructive pulmonary disease. The aim of this study was to evaluate the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy Ch
Autor:
Lingye Liu, Wen Yang, Yan Wang, Jin Lu, Li Ding, Xing Shi, Tengfei Li, Mtalimanja Michael, Shunbo Zhao
Publikováno v:
International journal of clinical pharmacology and therapeutics. 56(12)
Objectives The aim of the study was to investigate the pharmacokinetics and tolerability of salbutamol/ambroxol fixed-dose combination granules following single and multiple dosing in healthy Chinese subjects. Materials and methods This was a randomi
Publikováno v:
International journal of clinical pharmacology and therapeutics. 56(5)
Objectives The aims of the study were to investigate the potential drug-drug interaction between salbutamol and ambroxol, the bioequivalence of the new fixed-dose combination containing salbutamol and ambroxol compared with co-administration of the t
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 92
A simple and sensitive HPLC-MS/MS method was developed and fully validated for the simultaneous determination of amygdalin (AD) and paeoniflorin (PF) in human plasma. For both analytes, the method exhibited high sensitivity (LLOQs of 0.6ng/mL) by sel